STE.NYSESteris PLC

Form 4: STERIS CFO Michael Tokich Boosts Stake with Share and Option Acquisitions

Sentiment:

Insider Trading Report


STERIS plc's Senior Vice President and Chief Financial Officer, Michael J. Tokich, reported the acquisition of 2,223 ordinary shares and 7,908 employee stock options, significantly increasing his beneficial ownership in the company.

Better than expectedThe CFO acquired additional ordinary shares, increasing his direct stake in the company, which can be seen as a vote of confidence.The CFO was granted a significant number of employee stock options, aligning his incentives with long-term shareholder value creation.

Summary

  • Michael J. Tokich, Sr. Vice Pres., CFO of STERIS plc, acquired 2,223 ordinary shares on June 3, 2025, at a price of $0, likely indicating a grant or vesting event.
  • He also acquired 7,908 employee stock options on June 3, 2025, with an exercise price of $267.66 and an expiration date of June 3, 2035.
  • Following these transactions, Mr. Tokich directly beneficially owns 44,232 ordinary shares and 7,908 employee stock options.
  • An additional 3,592 ordinary share equivalents are held indirectly on his behalf under the STERIS Corporation 401(k) Plan as of June 2, 2025.
  • Of the directly held ordinary shares, 7,647 are restricted and will lapse on various dates between June 4, 2025, and June 5, 2028.
  • The acquired employee stock options will become exercisable in four equal tranches of 1,977 options each, annually from June 3, 2026, to June 4, 2029.

Sentiment

Score: 8

Explanation: The acquisition of shares and a substantial grant of stock options to a key executive like the CFO is generally viewed positively, indicating alignment of interests and confidence in the company's future performance.

Positives

  • The acquisition of 2,223 ordinary shares by a key executive, Michael J. Tokich, increases his direct ownership and aligns his interests with shareholders.
  • The grant of 7,908 employee stock options provides a significant long-term incentive for the CFO, linking his compensation to the company's future performance.
  • The employee stock options have a 10-year expiration period (until June 3, 2035), offering ample time for potential value realization.

Future Outlook

NA

Industry Context

This Form 4 filing reflects a routine insider transaction for a senior executive at STERIS plc, a company operating in the healthcare products and services industry. Such filings are common and provide transparency into executive compensation and ownership, but do not typically offer insights into broader industry trends or competitive dynamics.

Related Party Transactions

  • 3,592 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan.

Stakeholder Impact

  • Shareholders: Increased alignment of the CFO's interests with shareholders due to higher direct ownership and long-term stock options.
  • Employees: The grant of stock options is part of executive compensation, which can influence overall compensation structures.

Next Steps

  • Lapse of restrictions on 7,647 ordinary shares on various dates between June 4, 2025, and June 5, 2028.
  • Employee stock options becoming exercisable in four annual tranches of 1,977 options each, starting June 3, 2026, through June 4, 2029.

Key Dates

DateDescription
2025-06-02Date as of which 3,592 ordinary share equivalents are held indirectly under the STERIS Corporation 401(k) Plan.
2025-06-03Date of acquisition for 2,223 ordinary shares and 7,908 employee stock options.
2025-06-04Lapse date for 1,141 restricted ordinary shares.
2025-10-01Lapse date for 144 restricted ordinary shares.
2026-06-01Lapse date for 1,293 restricted ordinary shares.
2026-06-02Lapse date for 564 restricted ordinary shares.
2026-06-03Lapse date for 741 restricted ordinary shares and first exercisable date for 1,977 employee stock options.
2026-06-04Lapse date for 1,141 restricted ordinary shares.
2027-06-03Lapse date for 741 restricted ordinary shares and second exercisable date for 1,977 employee stock options.
2027-06-04Lapse date for 1,141 restricted ordinary shares.
2028-06-03Lapse date for 741 restricted ordinary shares.
2028-06-05Third exercisable date for 1,977 employee stock options.
2029-06-04Fourth exercisable date for 1,977 employee stock options.
2035-06-03Expiration date for the acquired employee stock options.

Keywords

STERIS plc, STE, Michael J. Tokich, CFO, Form 4, Insider Trading, Stock Options, Ordinary Shares, Beneficial Ownership, Restricted Stock, Employee Stock Option Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.